| Similar Articles |
|---|
 |
The Motley Fool
September 26, 2011
Brian Orelli |
Closer to Approval, Now Can MELA Find Customers? The restrictions might be too much. The company has been fighting for years to gain Food and Drug Administration approval of its melanoma detection device, MelaFind.   |
The Motley Fool
November 19, 2010
Brian Orelli |
Up 95%, but Still Risky as Heck That's an understatement for MELA Sciences. |
The Motley Fool
September 8, 2011
Brian Orelli |
All Approvals Are Not Created Equal MELA's EU approval for its skin cancer detector MelaFind isn't nearly as important as one stateside would be. |
The Motley Fool
August 18, 2011
Brian Orelli |
Running the Correct Trial Isn't Enough MELA Sciences' stock is up on claim that their trial meets FDA guidance, but they still need to prove that the device actually works. |
The Motley Fool
October 26, 2009
Dave Mock |
A Big Upgrade for Electro-Optical Sciences This bullish call comes from more than just one analyst. The Food and Drug Administration has put Electro-Optical Sciences' melanoma detection device on the fast track. |
The Motley Fool
September 21, 2011 |
One Hot Stock to Avoid Our investing community's latest prime pick to avoid: MELA Sciences. |
The Motley Fool
May 13, 2011
Brian Orelli |
FDA Advisory Panel Positive! Shares Punished. Despite the positive recommendation, investors aren't convinced BioMimetic's Augment will be approved. |
The Motley Fool
September 21, 2007
Billy Fisher |
Robotics' Momentum Continues MAKO Surgical files for an IPO. The medical device maker has designed a surgeon-interactive robotic system to assist orthopedic surgeons carry out more precise and less invasive osteoarthritic knee surgeries. |
The Motley Fool
January 4, 2012
Brian Orelli |
Mark Your Calendars, Biotech Investors Cell Therapeutics' advisory panel meet ought to be entertaining. |
The Motley Fool
February 16, 2010
Brian Orelli |
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. |
BusinessWeek
June 12, 2006
Catherine Arnst |
Going From The Lab To Limbo The FDA has been delaying decisions on applications, and drugmakers are fuming. |
The Motley Fool
October 19, 2007
Billy Fisher |
Defying Intuition at Intuitive Surgical Another round of good quarterly results brings another boost in surgical robot maker Intuitive Surgical's stock price. Investors, take note. |
The Motley Fool
January 13, 2012
Dan Caplinger |
Has Intuitive Surgical Become the Perfect Stock? What Intuitive Surgical needs to do to get even closer to perfection is to get to the point in its growth curve at which it's ready to start paying dividends. |
The Motley Fool
January 19, 2012
Anders Bylund |
Can This Moat Still Stave Off Invading Hordes? A closer look at Intuitive Surgical's competition only confirms the thesis: this moat is safe as houses. |
The Motley Fool
November 30, 2011
David Williamson |
Health Care's 5 Worst November Flops These stocks had a terrible month. |
The Motley Fool
June 8, 2011 |
One Medical-Device Stock to Avoid Our investing community's latest short pick: Mako Surgical. |
The Motley Fool
August 10, 2011
Evan Niu |
One Medical-Device Stock to Buy MAKO Surgical delivers strong results. |
The Motley Fool
August 21, 2009 |
3 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs. Take a look at: Actuate... ArthroCare... Medco Health Solutions... |
The Motley Fool
September 25, 2009 |
2 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs: Cellcom Israel Ltd... China BAK Battery, Inc... |
The Motley Fool
July 15, 2008
Brian Orelli |
Will a New Use Help Schering-Plough's Near-Blockbuster Drug? Delaying relapses probably won't be enough to get its Pegintron approved as a treatment for melanoma. |
The Motley Fool
December 1, 2011
David Meier |
Why I Am Buying MAKO Surgical MAKO Surgical is changing orthopedic surgery, one robot at a time. |
The Motley Fool
November 11, 2011
Evan Niu |
MAKO Surgical Is Breaking the Rules The company reports strong third-quarter revenue but still has yet to turn a profit. |
The Motley Fool
January 10, 2012
Evan Niu |
18 More Reasons to Love This Rule Breaker MAKO Surgical keeps on keeping on. |
